Skip to content

Homeopathic treatment of sciatica pain

Double-blind, randomized, placebo-controlled, feasibility trial of individualized homeopathic medicines in sciatica pain

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031477
Enrollment
42
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Homeopathic medicines in centesimal potencies: It is planned as administering indicated homeopathic remedies in centesimal potencies, as decided appropriate to the case or condition. In
dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Route of administration of medicin
dosage and repetition depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP)-certified firm. Route of administration: Oral.

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex 2. Age 18-65 years 3. Patients experiencing low back pain radiating to lower limb (unilateral or bilateral) since 3 months or more (2018/19 ICD-10-CM diagnosis code M54.31); confirmed by straight leg raising test. 4. Patients who are literate and capable of filling the questionnaire and providing informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from uncontrolled systemic diseases or infections; e.g. diabetes mellitus, cardiovascular diseases, thyroid diseases, etc. 2. Patients having history of surgery to the lower back 3. Patients suffering from disc prolapse, psoriatic arthritis and gout, cases willing for or requiring immediate surgical intervention or already underwent any major spinal or hip surgery in last 6 months. 4. Patients who are undergoing treatment with NSAIDS during 6 weeks prior to enrolment in the study 5. Spinal corticosteroid injection within 6 months 6. Diagnosed cases of unstable psychiatric illness 7. Pregnant, lactating and puerperial women 8. Self-reported immune-compromised state 9. Substance abuse and/or dependence

Design outcomes

Primary

MeasureTime frame
The Roland Morris pain and disability questionnaire (RMPDQ)Timepoint: At baseline and after 2 months

Secondary

MeasureTime frame
McGill pain questionnaire (MPQ)Timepoint: At baseline and after 2 months;Oswestry LBP questionnaireTimepoint: At baseline and after 2 months

Countries

India

Contacts

Public ContactIrfan Mondal

D. N. De Homoeopathic Medical College and Hospital

shyamalmukhergee@gmail.com9831113383

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026